Sign Up to like & get
recommendations!
0
Published in 2017 at "European Journal of Pharmaceutics and Biopharmaceutics"
DOI: 10.1016/j.ejpb.2017.04.012
Abstract: Graphical abstract Figure. No caption available. ABSTRACT Dutasteride, used for treating benign prostate hyperplasia (BPH), promotes hair growth. To enhance delivery to the hair follicles and reduce systemic effects, in this study dutasteride has been…
read more here.
Keywords:
dst nlcs;
stearic acid;
acid chitosan;
dutasteride ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Radiochimica Acta"
DOI: 10.1515/ract-2019-3156
Abstract: Abstract To assess the suitability of 99mTc labeled 5α-reductase (5α-Rds) inhibitors for non-invasive targeting of prostate cancer (PCa) using Male Sprague Dawely Rat (MSDR) model. In this work, dutasteride (Cpd-1) a 5α-Rds inhibitor was derivatized…
read more here.
Keywords:
cpd;
reductase;
target;
99mtc labeled ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "In Vivo"
DOI: 10.21873/invivo.12396
Abstract: Background/Aim: Curcumin is a natural compound of turmeric, which inhibits prostate cancer cell proliferation. This study examined whether treatment of LNCaP prostate cancer cells with the combination of curcumin and dutasteride, a 5-alpha reductase inhibitor,…
read more here.
Keywords:
lncap;
dutasteride;
prostate cancer;
cancer cells ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Annals of Dermatology"
DOI: 10.5021/ad.22.027
Abstract: Background Dutasteride improves hair growth compared with finasteride in male androgenic alopecia (AGA) and is well tolerated. However, real-world evidence for long-term dutasteride use in AGA is lacking. Objective To describe baseline characteristics, treatment patterns…
read more here.
Keywords:
long term;
safety;
male androgenic;
effectiveness ... See more keywords